Related Experiment Video

Updated: Jul 10, 2026

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

T-cell death and cancer immune tolerance

B Lu1, O J Finn

  • 1Department of Immunology, School of Medicine, University of Pittsburgh, 200 Lothrop Street, Pittsburgh, PA 15261, USA. Binfeng@pitt.edu

Cell Death and Differentiation
|November 17, 2007
PubMed

Insights

Cancer immune evasion involves T-cell death, hindering anti-tumor responses. Preventing T-cell death in the tumor microenvironment could enhance adaptive immunity against cancer.

Area of Science:

  • Immunology
  • Oncology
  • Cancer Research

Background:

  • Adaptive immune responses are crucial for cancer immunosurveillance.
  • Tumors employ diverse mechanisms to evade immune detection and destruction.
  • T-cell death is a key factor in developing tumor-induced immunotolerance.

Purpose of the Study:

  • To investigate the role of T-cell death in tumor immune evasion.
  • To identify therapeutic strategies targeting T-cell death to enhance anti-cancer immunity.

Main Methods:

  • Analysis of T-cell death mechanisms in the tumor microenvironment.
  • Evaluation of chronic and abortive T-cell stimulation by tumor antigens.
  • Assessment of T-cell death in tumor draining lymph nodes.

Main Results:

  • Chronic T-cell stimulation by tumors results in activation-induced cell death.
  • Tolerogenic antigen-presenting cells induce autonomous T-cell death.
  • T-cell death contributes significantly to tumor immunotolerance.

Conclusions:

  • Preventing T-cell death is a promising therapeutic strategy.
  • Interventions targeting T-cell death in the tumor microenvironment and lymph nodes can bolster anti-cancer adaptive immunity.

More Related Videos

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Special Features of Adaptive Immunity01:20

Special Features of Adaptive Immunity

The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...